There are 2137 resources available
CN9 - The European Cancer Nursing Index 2020: A tool for mapping cancer nursing status across Europe
Presenter: Lena Sharp
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
LBA31 - Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)
Presenter: Kathleen Moore
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
805O - ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or primary peritoneal carcinoma treatment
Presenter: Andrew Clamp
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
LBA32 - Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study
Presenter: Robert Coleman
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
807O - Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)
Presenter: Kohei Omatsu
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
1O - A study of cancer dissemination from metastatic intermediates of hypermethylated colorectal patients reveals a new mode of collective migration
Presenter: Emmanuel Dornier
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
1977O - Functional inactivation of E-cadherin drives EMT-less metastasis
Presenter: Saverio Alberti
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
2O - Growth differentiation factor 15 (GDF-15) neutralization reverses cancer cachexia, restores physical performance and mitigates emesis associated with platinum-based chemotherapy
Presenter: Zhidan Wu
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
3O - Efficacy of the triple combination of Estrogen Receptor, CDK4/6 and PI3K pathway inhibitors in ex-vivo models of breast cancer
Presenter: Anna Diana
Session: Proffered Paper - Basic Science
Resources:
Abstract
Slides
Webcast
700O - Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)
Presenter: Maxime Meylan
Session: Proffered Paper - GU, non prostate 2
Resources:
Abstract
Slides
Webcast